All Stories

  1. The adjuvant effect of bacterium-like particles depends on the route of administration
  2. Characterization of the Second Apoptosis Inhibitor Encoded by Guinea Pig Cytomegalovirus
  3. Intimate Adhesion Is Essential for the Pathogen-Specific Inflammatory and Immune Responses in the Gut of Mice Infected with Citrobacter rodentium
  4. The Guinea pig cytomegalovirus GP119.1 gene encodes an IgG‐binding glycoprotein that is incorporated into the virion
  5. Identification and functional analyses of a cell-death inhibitor encoded by guinea pig cytomegalovirus gp38.1 in cell culture and in animals
  6. Enhancement of guinea pig cytomegalovirus infection by two endogenously expressed components of the pentameric glycoprotein complex in epithelial cells
  7. Activation of c-Jun by human cytomegalovirus UL42 through JNK activation
  8. Roles of GP33, a guinea pig cytomegalovirus-encoded G protein-coupled receptor homolog, in cellular signaling, viral growth and inflammation in vitro and in vivo
  9. M cell–targeting strategy enhances systemic and mucosal immune responses induced by oral administration of nuclease-producing L. lactis
  10. Titration of cell-associated varicella-zoster virus with the MV9G reporter cell line for antiviral studies
  11. Differences in the effects of mutations in GP131, a guinea pig cytomegalovirus homologue of pentameric complex component UL130, on macrophage and epithelial cell infection
  12. Analysis of relationships between polymorphisms in the genes encoding the pentameric complex and neutralization of clinical cytomegalovirus isolates
  13. Effects of cationic liposomes with stearylamine against virus infection
  14. Characterization of phenyl pyrimidine derivatives that inhibit cytomegalovirus immediate-early gene expression
  15. Peyer’s Patches as a Portal for DNA Delivery by Lactococcus lactis in Vivo
  16. Vaccine Development for Cytomegalovirus
  17. Congenital cytomegalovirus in Japan: More than 2 year follow up of infected newborns
  18. Newborn Congenital Cytomegalovirus Screening Based on Clinical Manifestations and Evaluation of DNA-based Assays for In Vitro Diagnostics
  19. Characterization of an anti-varicella-zoster virus compound that targets the portal protein encoded by ORF54
  20. Characterization of a thienylcarboxamide derivative that inhibits the transactivation functions of cytomegalovirus IE2 and varicella zoster virus IE62
  21. Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment
  22. An Ex vivo culture model for placental cytomegalovirus infection using slices of Guinea pig placental tissue
  23. A Thr72Ala polymorphism in the NKG2D gene is associated with early symptomatic congenital cytomegalovirus disease
  24. Evidence for human herpesvirus-6B infection of regulatory T-cells in acute systemic lymphadenitis in an immunocompetent adult with the drug reaction with eosinophilia and systemic symptoms syndrome: A case report
  25. Aberrant fetal macrophage/microglial reactions to cytomegalovirus infection
  26. Low total IgM values and high cytomegalovirus loads in the blood of newborns with symptomatic congenital cytomegalovirus infection
  27. Molecular and Virological Evidence of Viral Activation From Chromosomally Integrated Human Herpesvirus 6A in a Patient With X-Linked Severe Combined Immunodeficiency
  28. The IgG avidity value for the prediction of congenital cytomegalovirus infection in a prospective cohort study
  29. Guinea pig cytomegalovirus GP129/131/133, homologues of human cytomegalovirus UL128/130/131A, are necessary for infection of monocytes and macrophages
  30. Unusually extensive disseminated herpes zoster with multiple ulcer formation in a methotrexate‐treated rheumatoid arthritis patient
  31. Intrauterine Growth Restriction Caused by Underlying Congenital Cytomegalovirus Infection
  32. The highly conserved human cytomegalovirus UL136 ORF generates multiple Golgi-localizing protein isoforms through differential translation initiation
  33. Quantitative evaluation of ventricular dilatation using computed tomography in infants with congenital cytomegalovirus infection
  34. The presence of antibodies against the AD2 epitope of cytomegalovirus glycoprotein B is associated with acute rejection after renal transplantation
  35. Polymorphisms in TLR-2 are associated with congenital cytomegalovirus (CMV) infection but not with congenital CMV disease
  36. Detection of human herpesviruses in the cerebrospinal fluid from patients diagnosed with or suspected of having progressive multifocal leukoencephalopathy
  37. Cytomegalovirus (CMV) glycoprotein H-based serological analysis in Japanese healthy pregnant women, and in neonates with congenital CMV infection and their mothers
  38. Effects of immunization of pregnant guinea pigs with guinea pig cytomegalovirus glycoprotein B on viral spread in the placenta
  39. Human Herpesvirus 6A, 6B, and 7 Encephalitis
  40. Human cytomegalovirus induces apoptosis in neural stem/progenitor cells derived from induced pluripotent stem cells by generating mitochondrial dysfunction and endoplasmic reticulum stress
  41. Cytomegalovirus Impairs Cytotrophoblast-Induced Lymphangiogenesis and Vascular Remodeling in an in Vivo Human Placentation Model
  42. Neonatal Herpes Encephalitis Caused by a Virologically Confirmed Acyclovir-Resistant Herpes Simplex Virus 1 Strain
  43. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection
  44. Identification of a Varicella-Zoster Virus Replication Inhibitor That Blocks Capsid Assembly by Interacting with the Floor Domain of the Major Capsid Protein
  45. Newborn screening of congenital cytomegalovirus infection using saliva can be influenced by breast feeding: Table 1
  46. Outcome of cochlear implantation in children with congenital cytomegalovirus infection or GJB2 mutation
  47. A Novel Real-Time PCR Method for Determination and Quantification of Each Cytomegalovirus Glycoprotein H Subtype in Clinical Samples
  48. Oral valganciclovir treatment for congenital cytomegalovirus infection
  49. Re-evaluation of the genome sequence of guinea pig cytomegalovirus
  50. Regulation of the expression of the varicella-zoster virus open reading frame 66 gene
  51. Efficacy of prolonged valganciclovir therapy for congenital cytomegalovirus infection
  52. Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study
  53. Single cytomegalovirus strain associated with fetal loss and then congenital infection of a subsequent child born to the same mother
  54. In vivo imaging assay for the convenient evaluation of antiviral compounds against cytomegalovirus in mice
  55. Lack of antibodies against the antigen domain 2 epitope of cytomegalovirus (CMV) glycoprotein B is associated with CMV disease after renal transplantation in recipients having the same glycoprotein H serotypes as their donors
  56. Is a 6-Week Course of Ganciclovir Therapy Effective for Chorioretinitis in Infants with Congenital Cytomegalovirus Infection?
  57. Varicella-zoster virus (VZV)
  58. Transmission of Varicella Vaccine Virus, Japan
  59. Characterization of the guinea pig cytomegalovirus genome locus that encodes homologs of human cytomegalovirus major immediate-early genes, UL128, and UL130
  60. Dried Umbilical Cords in the Retrospective Diagnosis of Congenital Cytomegalovirus Infection as a Cause of Developmental Delays
  61. Identification of a 1.6 kb genome locus of guinea pig cytomegalovirus required for efficient viral growth in animals but not in cell culture
  62. Genetic linkage among human cytomegalovirus glycoprotein N (gN) and gO genes, with evidence for recombination from congenitally and post-natally infected Japanese infants
  63. Identification of a highly conserved region in the human cytomegalovirus glycoprotein H gene and design of molecular diagnostic methods targeting the region
  64. Establishment of a Cell-Based Assay for Screening of Compounds Inhibiting Very Early Events in the Cytomegalovirus Replication Cycle and Characterization of a Compound Identified Using the Assay
  65. Genetic variations in the gB, UL144 and UL149 genes of human cytomegalovirus strains collected from congenitally and postnatally infected Japanese children
  66. EVALUATION OF SCREENING TESTS FOR CONGENITAL CYTOMEGALOVIRUS INFECTION
  67. Association of the Outcome of Renal Transplantation with Antibody Response to Cytomegalovirus Strain--Specific Glycoprotein H Epitopes
  68. Etiology of Severe Sensorineural Hearing Loss in Children: Independent Impact of Congenital Cytomegalovirus Infection and GJB2 Mutations
  69. Real-Time PCR Assay Using Specimens on Filter Disks as a Template for Detection of Cytomegalovirus in Urine
  70. Pathogenesis of cytomegalovirus-associated labyrinthitis in a guinea pig model
  71. Human herpesvirus 8 genoprevalence in populations at disparate risks of Kaposi's sarcoma
  72. Congenital Cytomegalovirus Infection Diagnosed by Polymerase Chain Reaction With the Use of Preserved Umbilical Cord in Sensorineural Hearing Loss Children
  73. Generation of a Reporter Cell Line for Detection of Infectious Varicella-Zoster Virus and Its Application to Antiviral Studies
  74. Comparison of serologic responses between Kaposi's sarcoma‐positive and ‐negative men who were seropositive for both human herpesvirus 8 and human immunodeficiency virus
  75. Inhibition of Infection and Replication of Human Herpesvirus 8 in Microvascular Endothelial Cells by Alpha Interferon and Phosphonoformic Acid
  76. Short Duration of Elevated vIRF-1 Expression during Lytic Replication of Human Herpesvirus 8 Limits Its Ability To Block Antiviral Responses Induced by Alpha Interferon in BCBL-1 Cells
  77. Retrospective Diagnosis of Congenital Cytomegalovirus Infection Using Dried Umbilical Cords
  78. Salivary production of IgA and IgG to human herpes virus 8 latent and lytic antigens by patients in whom Kaposi's sarcoma has regressed
  79. Characterization of Entry Mechanisms of Human Herpesvirus 8 by Using an Rta-Dependent Reporter Cell Line
  80. Characterization of Entry Mechanisms of Human Herpesvirus 8 by Using an Rta-Dependent Reporter Cell Line
  81. Glycoproteins M and N of human herpesvirus 8 form a complex and inhibit cell fusion
  82. Identification and characterization of the gene products of open reading frame U86/87 of human herpesvirus 6
  83. Activation of Cellular and Heterologous Promoters by the Human Herpesvirus 8 Replication and Transcription Activator
  84. Validation of AAV-mediated gene targeting
  85. Differences in DNA Binding Specificity among Roseolovirus Origin Binding Proteins
  86. Comparison of Serologic Assays for Detection of Antibodies against Human Herpesvirus 8
  87. Sequence Requirements for Interaction of Human Herpesvirus 7 Origin Binding Protein with the Origin of Lytic Replication
  88. Introduction of Single Base Substitutions at Homologous Chromosomal Sequences by Adeno-associated Virus Vectors
  89. New Immunofluorescence Assays for Detection ofHuman Herpesvirus 8-Specific Antibodies
  90. U94, the Human Herpesvirus 6 Homolog of the Parvovirus Nonstructural Gene, Is Highly Conserved among Isolates and Is Expressed at Low mRNA Levels as a Spliced Transcript
  91. Herpesviruses beyond HSV-1 and -2
  92. Physical and genetic maps of the human herpesvirus 7 strain SB genome
  93. Restriction endonuclease mapping and molecular cloning of the human herpesvirus 6 variant B strain Z29 genome
  94. Frequent isolation of human herpesvirus 7 from saliva
  95. Comparative Sequence Analyses of Epstein-Barr Virus Nuclear Antigen-2 and -3B Genes of a Fresh Epstein-Barr Virus-2 Isolate
  96. Analysis of Antibody Titers to Epstein-Barr Virus Nuclear Antigens in Sera of Patients with Sjogren's Syndrome and with Rheumatoid Arthritis
  97. The domain of Epstein-Barr virus nuclear antigen 1 essential for binding to oriP region has a sequence fitted for the hypothetical basic-helix-loop-helix structure
  98. Synthesis of fusion proteins of Epstein-Barr virus nuclear antigens in E. coli and their antigenicity
  99. Transcription and initiation of ColE1 DNA replication in Escherichia coli K-12.
  100. Isolation and characterization of herC, a mutation of Escherichia coli affecting maintenance of ColE1
  101. Newly Identified Human Herpesviruses: HHV-6, HHV-7, and HHV-8